We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$559M
AUM Growth
-$6.54M
Cap. Flow
-$4.83M
Cap. Flow %
-0.87%
Top 10 Hldgs %
65.7%
Holding
77
New
3
Increased
6
Reduced
4
Closed
2

Top Buys

1
FGNA.U
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
+$5M
2
ADVM
Adverum Biotechnologies
ADVM
+$2.25M
3
TGTX icon
TG Therapeutics
TGTX
+$1.61M
4
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$1.02M
5
FATE icon
Fate Therapeutics
FATE
+$697K

Top Sells

1
ARKO icon
ARKO Corp
ARKO
+$10.3M
2
BLFS icon
BioLife Solutions
BLFS
+$3.46M
3
FLNA
Filana Therapeutics
FLNA
+$1.65M
4
DRRX
DURECT Corp
DRRX
+$501K
5
CUE icon
Cue Biopharma
CUE
+$288K

Sector Composition

1 Healthcare 22.73%
2 Industrials 17.34%
3 Energy 10.35%
4 Materials 8.21%
5 Consumer Discretionary 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NS
26
DELISTED
NuStar Energy L.P.
NS
$4.63M 0.83%
435,500
– –
BX icon
27
Blackstone
BX
$155B
$4.18M 0.75%
80,000
– –
FATE icon
28
Fate Therapeutics
FATE
$330M
$4M 0.72%
100,000
+19,972
+25% +$697K
LSXMA
29
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.44M 0.61%
141,002
– –
JPM icon
30
JPMorgan Chase
JPM
$912B
$2.89M 0.52%
30,000
– –
AXP icon
31
American Express
AXP
$243B
$2.51M 0.45%
25,000
– –
AMP icon
32
Ameriprise Financial
AMP
$47.6B
$2.46M 0.44%
15,993
– –
DNTH icon
33
Dianthus Therapeutics
DNTH
$5.65B
$2.39M 0.43%
21,992
– –
OIG
34
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2.29M 0.41%
92,514
– –
CUE icon
35
Cue Biopharma
CUE
$129M
$2.26M 0.4%
5,000
-500
-9% -$288K
DISH
36
DELISTED
DISH Network Corp.
DISH
$2.25M 0.4%
77,500
– –
IHC
37
DELISTED
Independence Holding Company
IHC
$2.06M 0.37%
54,711
– –
EPD icon
38
Enterprise Products Partners
EPD
$83.1B
$1.99M 0.36%
126,301
– –
TGTX icon
39
TG Therapeutics
TGTX
$8.39B
$1.87M 0.34%
+70,000
New +$1.61M
DUOT icon
40
Duos Technologies
DUOT
$263M
$1.73M 0.31%
453,616
– –
ADVM
41
DELISTED
Adverum Biotechnologies
ADVM
$1.54M 0.28%
+15,000
New +$2.25M
LBTYK icon
42
Liberty Global Class C
LBTYK
$3.4B
$1.43M 0.26%
69,618
– –
BLUE
43
DELISTED
bluebird bio
BLUE
$1.35M 0.24%
1,930
– –
ORTX
44
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.03M 0.18%
25,000
+12,480
+100% +$645K
PYPL icon
45
PayPal
PYPL
$50.3B
$985K 0.18%
5,000
– –
RIBT
46
DELISTED
RiceBran Technologies
RIBT
$715K 0.13%
170,333
– –
LBTYA icon
47
Liberty Global Class A
LBTYA
$3.52B
$483K 0.09%
22,989
– –
GRTS
48
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$448K 0.08%
169,039
– –
BATRK icon
49
Atlanta Braves Holdings Series B
BATRK
$3.32B
$435K 0.08%
20,717
– –
RTX icon
50
RTX Corp
RTX
$262B
$345K 0.06%
6,000
– –
1
2
3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q3 2020 Portfolio in Review

As of Q3 2020, Bleichroeder LP held 77 positions worth $559M, down 1.2% from $565M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bleichroeder LP's Q3 2020 filing shows 3 new, 6 increased, 4 reduced and 2 closed positions. Its largest new stake was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M. The largest sale was ARKO Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Energy.

  • Bleichroeder LP's largest Q3 2020 buy was FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one: 500,000 shares worth $5M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q3 2020, an estimated $1.02M increase.
  • Bleichroeder LP's biggest Q3 2020 reduction was Filana Therapeutics, cutting an estimated $1.65M.
  • Bleichroeder LP fully exited ARKO Corp in Q3 2020, selling an estimated $10.3M.
  • Bleichroeder LP's ten largest holdings make up 66% of its $559M portfolio in Q3 2020.
  • Bleichroeder LP opened 3 new positions and closed 2 in Q3 2020.
  • Bleichroeder LP's portfolio value fell 1.2% quarter-over-quarter to $559M.

Based on Bleichroeder LP's 13F filing for Q3 2020, filed 12 Nov 2020.